符合新生儿低血糖筛查条件的婴儿比例:一项系统综述
结果显示指南质量参差且筛查标准缺乏共识,总体26.3%的婴儿符合筛查条件,15年间比例从25.6%升至28.5%但校正后无统计学意义。
要点
- 最高评分指南定义筛查标准为IDM、早产<37周、SGA<10百分位、出生体重<2500g或>4500g、LGA>90百分位或胎龄>42周。
- 15年间符合筛查比例从25.6%升至28.5%,但校正母亲年龄、BMI、种族和多胎妊娠后无统计学意义。
核心结论
- 系统综述发现新生儿低血糖实践指南质量参差,且对高危婴儿的定义缺乏共识。
- 队列研究中约四分之一婴儿符合低血糖筛查条件。
- 需进一步研究确定哪些婴儿可从新生儿低血糖筛查中获益。
研究设计与样本
- 系统综述检索并评价新生儿低血糖临床实践指南,采用AGREE II工具评估。
- 使用最高评分指南的筛查标准确定符合筛查条件的婴儿比例,数据分析采用逻辑回归。
主要发现
- 共筛选2366篇摘要,18部指南符合纳入标准进行评价。
- 指南质量存在差异,筛查标准之间缺乏共识。
- 队列婴儿中位(IQR)胎龄为39(38-40)周,51%为男性。
- 总体符合筛查条件的婴儿比例为26.3%。
- 15年间符合筛查比例从25.6%升至28.5%,校正母亲年龄、BMI、种族和多胎妊娠后OR为0.99(95%CI 0.93-1.03),无统计学意义。
关键数值与推荐
- 最高评分指南的筛查标准为:IDM、早产(胎龄<37周)、SGA(<10百分位)、出生体重<2500g或>4500g、LGA(>90百分位)或胎龄>42周。
- 队列纳入标准为胎龄≥35周、出生体重≥2000g且生后1小时内未入NICU。
- 总体符合筛查比例26.3%,15年变化校正后OR 0.99(95%CI 0.93-1.03)。
临床怎么用
- 可参考最高评分指南的筛查标准识别新生儿低血糖高危儿。
- 约四分之一符合条件的婴儿需要筛查,应合理配置筛查资源。
- 指南间筛查标准缺乏共识,临床实施时需结合本机构指南。
局限性
- 仅基于最高评分指南的筛查标准评估符合比例。
- 为回顾性观察队列研究,机构指南质量参差且标准缺乏共识可能影响结果外推。
- 研究未评估筛查对临床结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Neonatal hypoglycemia is common, occurring in up to 50% of infants at risk for hypoglycemia (infant of diabetic mother [IDM], small for gestational age [SGA], large for gestational age [LGA], and preterm) and is associated with long-term neurodevelopmental impairment. Guidelines recommend screening infants at risk of hypoglycemia. The proportion of infants who require screening for neonatal hypoglycemia is unknown. OBJECTIVE: To determine the proportion of infants eligible for neonatal hypoglycemia screening using criteria from the highest-scoring critically appraised clinical guideline. DESIGN, SETTING, AND PARTICIPANTS: This systematic review of the literature was conducted to identify clinical practice guidelines for neonatal hypoglycemia and took place at a tertiary maternity hospital in Auckland, New Zealand. Eligible guidelines were critically appraised using the Appraisal of Guidelines for Research and Evaluation II tool. Using screening criteria extracted from the highest-scoring guideline, the proportion of infants eligible for neonatal hypoglycemia screening was determined in a retrospective observational cohort study of infants born January 1, 2004, to December 31, 2018. Data were analyzed by logistic regression. Infant participants were included if gestational age was 35 weeks or more, birth weight was 2000 g or more, and they were not admitted to a neonatal intensive care unit less than 1 hour after birth. The data were analyzed from November 2022 through February 2023. A total of 101 372 infants met the inclusion criteria. EXPOSURE: Risk factors for neonatal hypoglycemia. MAIN OUTCOME: Proportion of infants eligible for neonatal hypoglycemia screening. RESULTS: The study team screened 2366 abstracts and 18 guidelines met inclusion criteria for appraisal. There was variability in the assessed quality of guidelines and a lack of consensus between screening criteria. The highest-scoring guideline defined screening criteria as: IDM, preterm (less than 37 weeks' gestation), SGA (less than 10th percentile), birth weight of less than 2500 g or more than 4500 g, LGA (more than 90th percentile), or gestational age more than 42 weeks. A total of 101 372 infants met criteria for inclusion in the cohort study; median (IQR) gestational age was 39 (38-40) weeks and 51% were male. The overall proportion of infants eligible for screening was 26.3%. There was an increase in the proportion of eligible infants from 25.6% to 28.5% over 15 years, which was not statistically significant after adjustment for maternal age, body mass index, ethnicity, and multiple pregnancy (odds ratio, 0.99; 95% CI, 0.93-1.03; change in proportion per year). CONCLUSION: A systematic review found that practice guidelines providing recommendations for clinical care of neonatal hypoglycemia were of variable quality with is a lack of consensus regarding definitions for infants at risk for hypoglycemia. In the cohort study, one-quarter of infants were eligible for hypoglycemia screening. Further research is required to identify which infants may benefit from neonatal hypoglycemia screening.
引用
- O'Brien M, Gilchrist C, Sadler L, et al. Infants Eligible for Neonatal Hypoglycemia Screening: A Systematic Review. JAMA Pediatr. 2023. PMID: 37782488. doi:10.1001/jamapediatrics.2023.3957
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。